Wednesday, August 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 21, 2026

GM releases 2026 second-quarter results, raises full-year 2026 guidance and declares quarterly dividend

View original at finance.yahoo.com
GM releases 2026 second-quarter results, raises full-year 2026 guidance and declares quarterly dividend DETROIT, July 21, 2026 /PRNewswire/ -- General Motors (NYSE: GM) today reported second-quarter 2026 revenue of $48.0 billion, net income attributable to stockholders of $1.3 billion, and EBIT-adjusted of $3.9 billion…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • GM is raising its full-year 2026 EBIT-adjusted guidance for the second time this year.

    60% confidence

  • These expected full-year 2026 financial results do not include the potential impact of future adjustments related to special items.

    60% confidence

  • GM's Board of Directors declared a quarterly cash dividend of $0.18 per share, payable September 17, 2026, to holders of record as of September 4, 2026.

    60% confidence

  • GM expects full-year 2026 net income attributable to stockholders of $8.4 billion to $9.8 billion, automotive operating cash flow of $15.4 billion to $19.4 billion, and EPS-diluted of $8.98 to $10.98.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
GM releases 2026 second-quarter results, raises full-year 2026 guidance and declares quarterly dividend — Source | Via News | ViaNews Market